Tag Archives: data

In Covid-19 Vaccine Data, LGBTQ People Fear Invisibility

The Coronavirus Outbreak liveLatest Updates Maps and Cases Vaccine Rollout Second Dose Outdoor Mask Guidance Josie Nixon of Denver, Colo. had to select “other” for her gender when registering for a Covid vaccine. There was no option for “transgender woman.”Credit…Caleb Alvarado for The New York Times SectionsSkip to contentSkip to site index In Covid Vaccine… Read More »

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects

While much of the world focused on Pfizer and BioNTech’s positive COVID-19 vaccine news on Monday, analysts started gaming out potential ripple effects, namely for companies making coronavirus therapeutics. A promising COVID-19 vaccine is obviously good news for drugmakers and the world at large, but companies developing and selling coronavirus treatments could see lower sales down the line, Barclays analysts wrote… Read More »

Acronis Expands Regional Support for Partners, Deploying Local Cyber Data Centres and Enhancing Acronis Cyber Infrastructure

LONDON, UK, 20 October 2020 – Acronis today announced plans to expand its global network of cloud data centres. Announced at the Acronis Global Cyber Summit 2020, the expansion ensures that the full range of Acronis Cyber Protection Solutions will be available to partners and organisations around the world, which is critical now that an… Read More »

ESMO: New Trodelvy breast, bladder cancer data show why Gilead’s going big for Immunomedics

Compared with the spate of multibillion-dollar buyouts last year, biopharma M&A has been relatively quiet in 2020—until last week, when Gilead Sciences surprised the market with its $ 21 billion purchase of Immunomedics. Now, two sets of new cancer data from Immunomedics’ first-in-class antibody-drug conjugate Trodelvy offer a glimpse into why Gilead paid such big money… Read More »

Novavax’s coronavirus vaccine generates promising immune response in early trial, data shows

Dr. Sonia Macieiewski (R) and Dr. Nita Patel, Director of Antibody discovery and Vaccine development, look at a sample of a respiratory virus at Novavax labs in Rockville, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. Andrew Caballero-Reynolds | AFP | Getty Images Novavax announced Tuesday its… Read More »